Control of uterine hyperactivity caused by prostaglandin with intravenous terbutaline: a case report.
Prostaglandin E2 is beginning to be used more widely for the induction of labor in this country. The main concern with vaginal administration is the difficulty in stopping uterine hyperactivity. This report is a case where intravenous terbutaline was given as soon as hyperactivity and fetal heart rate deceleration were detected. Using this treatment, hyperactivity was controlled and the fetal heart rate returned to normal. Unfortunately, cesarean section was necessary for fetal distress which developed two and a half hours later when syntocinon was started intravenously to augment the labor.
Herabutya
Y
Y
Department of Obstetrics & Gynaecology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
O-Prasertsawat
P
P
D000328:Adult; D015148:Cardiotocography; D015232:Dinoprostone / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007751:Labor, Induced; D011247:Pregnancy; D013726:Terbutaline / Q000008:administration & dosage*; D014590:Uterine Contraction / Q000187:drug effects*
D015232:Dinoprostone; D013726:Terbutaline